MedTrace Logo

Scalp Block Versus Scalp Infiltration With Dexmedetomidine and Local Anesthetic for Post Craniotomy Pain

NCT02866409 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-08-15

No results posted yet for this study

Summary

This study has been designed to assess the efficacy of dexmedetomidine as an adjuvant to local anaesthetic agent bupivacaine in scalp nerve block and scalp infiltration to control post craniotomy pain.A third group where patients were administered bupivacaine only infiltration has also been created.

Conditions

Interventions

PROCEDURE

scalp block

In this group following nerves were blocked- 1. Supra-orbital nerve 2. Supra-trochlear nerve 3. Zygomatico-temporal nerve 4. Auriculo-temporal nerve 5. Posterior auricular branches of the greater auricular Nerve 6. The greater, lesser, and third occipital nerves

PROCEDURE

infiltration

The incision site was infiltrated with drug. {1/3rd in the muscle and 2/3rd in the subcutaneous tissue}.

DRUG

Dexmedetomidine

Dexmedetomidine was administered as a dose of 1 µg/kg in 20 ml 0.25% bupivacaine for scalp block or infiltration.

DRUG

Bupivacaine

20 ml of Bupivacaine 0.25% was administered to the patients either in the form of scalp block or infiltration

Sponsors & Collaborators

  • Post Graduate Institute of Medical Education and Research, Chandigarh

    collaborator OTHER

  • NAVNEH SAMAGH

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-12-31
Completion
2015-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02866409 on ClinicalTrials.gov